T-cell-targeted peptide epitope vaccine (Emergex)

N/A

Report date: 2025/01/26 16:40:57

Base Information

Drug NameT-cell-targeted peptide epitope vaccine (Emergex)
Drug Alias NameT-cell-targeted peptide epitope vaccine (Emergex)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGylden Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGylden Pharma Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A